Dominican Barahona Coffee (Coffea arabica 'Dominican Barahona')

Dominican Barahona Coffee (Coffea arabica 'Dominican Barahona') is a single-origin arabica cultivar grown in the Barahona region of the Dominican Republic, notable for its exceptionally high concentrations of caffeoylquinic acids (CQAs), which drive its antioxidant activity. These CQAs, measured at up to 564.8 mg/100 mL in espresso preparations, scavenge free radicals via hydrogen atom transfer and single-electron transfer mechanisms, as confirmed by DPPH and FRAP assays.

Origin & History

Dominican Barahona Coffee is a cultivar variant of Coffea arabica grown in the high-altitude Barahona region of the Dominican Republic, where elevation influences bean quality and chemical composition. The beans are typically roasted and brewed, containing caffeoylquinic acids (CQAs), caffeine, trigonelline, and theobromine as primary bioactive compounds.

Historical & Cultural Context

No historical or traditional medicinal uses are documented for Dominican Barahona Coffee in available research. C. arabica is primarily cultivated as a beverage crop, with chemical profiles influenced by origin and altitude rather than traditional therapeutic applications.

Health Benefits

• Antioxidant activity through caffeoylquinic acids (CQAs) and alkaloids showing strong correlations with DPPH (r=0.543) and FRAP (r=0.991) assays - evidence from chemical analysis only
• Potential free radical scavenging properties from CQAs (up to 564.8 mg/100 mL in espresso preparations) - preliminary evidence
• Natural caffeine content (1.32-1.42%) may support alertness - general coffee evidence, not cultivar-specific
• Rich in polyphenols including multiple CQA isomers (3-CQA, 4-CQA, 5-CQA) - chemical profile data only
• Contains trigonelline and theobromine alkaloids (up to 815.1 mg/100 mL total alkaloids) - compositional data without clinical validation

How It Works

The primary bioactive compounds in Dominican Barahona Coffee are caffeoylquinic acids (CQAs), including chlorogenic acid and its isomers, which donate hydrogen atoms or electrons to neutralize reactive oxygen species (ROS) via both hydrogen atom transfer (HAT) and single-electron transfer (SET) pathways. CQAs also inhibit NADPH oxidase and modulate Nrf2/ARE signaling, upregulating endogenous antioxidant enzymes such as superoxide dismutase and catalase. Alkaloids present in the cultivar, including caffeine, contribute additional antioxidant capacity and may inhibit phosphodiesterase enzymes, amplifying intracellular cAMP signaling.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Dominican Barahona Coffee were identified. Available research focuses solely on chemical profiling and antioxidant assays of general C. arabica cultivars, with no PubMed-indexed clinical studies found for this specific variant.

Clinical Summary

Available evidence for Dominican Barahona Coffee's health effects is currently limited to in vitro chemical analysis rather than human clinical trials or animal intervention studies. Antioxidant capacity has been quantified using DPPH radical scavenging and FRAP (ferric reducing antioxidant power) assays, with CQA content reaching up to 564.8 mg/100 mL in espresso preparations and showing a strong linear correlation with FRAP values (r=0.991) and a moderate correlation with DPPH (r=0.543). No randomized controlled trials, cohort studies, or dose-response studies specific to this cultivar have been published, meaning all health benefit claims remain preliminary and are extrapolated from the broader chlorogenic acid and arabica coffee literature. Independent clinical validation in human subjects is required before any therapeutic or preventive health claims can be substantiated.

Nutritional Profile

Dominican Barahona coffee (brewed) is a low-calorie beverage (~2-5 kcal per 8 fl oz serving) with negligible macronutrient content (<0.3 g protein, <0.1 g fat, <0.5 g carbohydrates per cup). Key bioactive compounds include: **Caffeine**: 1.32–1.42% dry weight basis (approximately 80–120 mg per 8 fl oz brewed cup, varying with preparation method). **Caffeoylquinic acids (CQAs)**: dominant chlorogenic acid fraction, with espresso preparations yielding up to 564.8 mg/100 mL; 5-O-caffeoylquinic acid (5-CQA) is the predominant isomer, with 3-CQA and 4-CQA also present; total chlorogenic acid content in green beans estimated at 5.5–8.0 g/100 g dry weight (reduced by 50–70% during roasting depending on roast level). **Trigonelline**: approximately 0.8–1.2% dry weight in green beans, partially degraded to nicotinic acid (niacin/vitamin B3) during roasting, contributing roughly 1–3 mg niacin per cup. **Diterpenes**: cafestol and kahweol present in coffee oils (~0.2–0.6% of green bean dry weight each); concentrations in brewed cup depend heavily on filtration method (paper filtering removes >95%, while espresso and French press retain significant amounts at 2–6 mg/cup). **Minerals**: potassium (approximately 116 mg per 8 fl oz cup, ~3% DV), magnesium (7–12 mg, ~2–3% DV), trace amounts of manganese (~0.05 mg), phosphorus (~7 mg), and chromium. **Melanoidins**: formed during Maillard reactions in roasting, constitute up to 25% of dry weight in roasted beans; act as dietary fiber analogs and contribute to antioxidant capacity; poorly absorbed in the upper GI tract, reaching the colon where they may exert prebiotic effects. **B-vitamins**: small amounts of riboflavin (vitamin B2, ~0.2 mg/cup, ~11% DV) and pantothenic acid (vitamin B5, ~0.6 mg/cup, ~6% DV). **Bioavailability notes**: Chlorogenic acids are partially hydrolyzed in the small intestine (approximately 30% absorbed); the remainder reaches the colon where microbial metabolism produces caffeic acid and dihydrocaffeic acid, which are subsequently absorbed. Caffeine is nearly 100% bioavailable with rapid absorption (peak plasma at 30–60 min). Diterpene bioavailability is preparation-dependent. As a Coffea arabica cultivar from the Barahona region of the Dominican Republic, grown at elevations of approximately 600–1,300 meters, beans may have slightly higher chlorogenic acid concentrations compared to lower-altitude arabica cultivars due to slower maturation and increased secondary metabolite accumulation.

Preparation & Dosage

No clinically studied dosage ranges are available for Dominican Barahona Coffee. General C. arabica espresso preparations contain 564.8 mg/100 mL CQAs and up to 815.1 mg/100 mL alkaloids, but no standardization or clinical dosing has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, rhodiola, ashwagandha, cocoa extract

Safety & Interactions

Dominican Barahona Coffee shares the safety profile of standard Coffea arabica preparations; caffeine content poses risks of insomnia, tachycardia, hypertension, and anxiety at high consumption levels, with sensitive individuals advised to limit intake to under 400 mg caffeine per day. CQAs can increase gastric acid secretion and may exacerbate symptoms in individuals with gastroesophageal reflux disease (GERD) or peptic ulcers. Caffeine interacts with adenosine receptor antagonism and may potentiate stimulant medications, reduce efficacy of sedatives and benzodiazepines, and interact with anticoagulants such as warfarin by altering CYP1A2 metabolism. Pregnant individuals are advised to limit caffeine intake to under 200 mg per day per major obstetric guidelines, and those with hypertension or arrhythmias should consult a physician before regular high-dose consumption.